RxDoctor Payments Data

Kellie Aarons, MD

Family Medicine · Tampa, FLNPI 1558865477

Payments from drug & device makers

$1,241in general payments, 2019–2025

Across 63 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$254
  • Novo Nordisk$118
  • AstraZeneca$114
  • Bayer$111
  • Lilly USA, LLC$111
  • Amgen$98
  • plus $436 from 14 others

What the payments were for

  • Food & beverage$1,19796%
  • Other$444%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,241 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$38,212
Medicare patients
204
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide44$71,642
EliquisApixaban52$67,906
OzempicSemaglutide36$46,481
JanuviaSitagliptin Phosphate30$42,508
JardianceEmpagliflozin11$19,437
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,954
EntrestoSacubitril/Valsartan11$10,249
Atorvastatin Calcium455$5,521
Levothyroxine Sodium372$4,254
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$4,205
Losartan Potassium292$3,418
Citalopram HbrCitalopram Hydrobromide75$2,968
Albuterol Sulfate HfaAlbuterol Sulfate74$2,419
Lisinopril301$2,335
Omeprazole162$2,289

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$111$71,64244 claims
PfizerEliquis$37$67,90652 claims
Novo NordiskOzempic$118$46,48136 claims
Boehringer IngelheimJardiance$17$19,43711 claims
GSKTrelegy Ellipta$70$15,95417 claims
NovartisEntresto$30$10,24911 claims
AbbVieSynthroid$15$2,24628 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →